A non-bioabsorbable, implantable device intended to induce a neurovascular thrombosis to treat an intracranial aneurysm and/or neurovascular arteriovenous malformation (AVM); it may also be intended to treat non-neurovascular malformations. It is in the form o
| Company | Devices | Share |
|---|---|---|
| Microvention, Inc. | 1,591 | 33% |
| Micro Therapeutics, Inc. | 1,187 | 25% |
| Balt Usa Llc | 623 | 13% |
| Microport Neurotech (Shanghai) Co., Ltd. | 353 | 7% |
| Cerenovus, Inc. | 327 | 7% |
| Shanghai Wallaby Medical Technologies Co., Inc. | 299 | 6% |
| Penumbra, Inc. | 254 | 5% |
| Stryker Corporation | 105 | 2% |
| Sequent Medical, Inc. | 39 | 1% |
| Cook Incorporated | 19 | 0% |
| Enlight Medical Technologies(Shenzhen) Co., Ltd. | 4 | 0% |
Company = labeler of record on GUDID. 11 companies in total; top 12 shown. Click headers to sort.
Sample of brand names as labelled; no endorsement. Ask us for the full list with company, model and UDI.
| Code | Name | Devices |
|---|---|---|
| KRD | Device, Vascular, for Promoting Embolization | 3,249 |
| HCG | DEVICE, NEUROVASCULAR EMBOLIZATION | 3,166 |
| HCG | Device, Neurovascular Embolization | 1,283 |
| KRD | Device, Vascular, For Promoting Embolization | 932 |
| OPR | Intrasaccular Flow Disruption Device | 96 |
| MOF | Guide, Wire, Catheter, Neurovasculature | 4 |
Use these as the dimensions to specify in a tender line.
4,801 device records in commercial distribution are listed on the FDA Global Unique Device Identification Database (GUDID) under the GMDN category "Neurovascular embolization coil", from 11 companies. The largest labeler is Microvention, Inc. with 33% of records.
KRD (Device, Vascular, for Promoting Embolization), HCG (DEVICE, NEUROVASCULAR EMBOLIZATION), HCG (Device, Neurovascular Embolization), KRD (Device, Vascular, For Promoting Embolization)
No. GUDID is the US register. For the UAE (MOHAP/DoH) and Saudi (SFDA/MDMA) a separate registration and a local authorised representative are required; Consulting Wallah can check the status and connect you with registered suppliers.
Add neurovascular embolization coil to the RFQ basket or use the form below with quantity, specification and delivery location; the Network returns comparable quotes from verified suppliers in 2–5 working days.
Hospitals, pharmacies and distributors anywhere: tell us what you need and the Consulting Wallah Network returns comparable quotes from verified suppliers. No fee for buyers.
Source: FDA AccessGUDID (AccessGUDID full release 2 Nov 2026); counts are device records in commercial distribution grouped by GMDN preferred term; companies are labelers of record. Information only — US listing is not a registration in the UAE or GCC; verify with the regulator. © Consulting Wallah — CC BY‑NC‑ND.